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UNIT 10.7Cartridge Methods for Oligonucleotide
Purification
This unit provides protocols for DMTr (trityl)-selective (see Basic Protocol 1) and affinity
desalting (see Basic Protocol 2) purification of oligonucleotides. The protocols are
applicable for many of the convenient, disposable products for rapid oligonucleotide
purification, clean-up by selective adsorption, and elution on solid-phase media. Many of
the products are prepackaged, one-time use cartridges or columns filled with affinity or
size-exclusion media.
     BASIC
PROTOCOL 1
DMTr-SELECTIVE CARTRIDGE PURIFICATION
This protocol describes purification of tritylated oligonucleotides with the Oligonu-
cleotide Purification Cartridge (OPC, PE Applied Biosystems). The OPC can desalt,
detritylate, and purify tritylated oligonucleotides directly from the ammonium hydroxide
solution after cleavage/deprotection (McBride et al., 1988; Applied Biosystems, 1991;
Blocker et al., 1991).
The purity level achieved by OPC is appropriate for such common applications as
sequencing primers, PCR primers, and hybridization probes. Upon loading, the tritylated
oligonucleotide is retained by the hydrophobic polystyrene medium, while the salts,
non-tritylated oligonucleotides, and other impurities are not retained, and are washed
away. The trityl group of the OPC-bound oligonucleotide is removed with a brief acid
treatment, and the full-length, detritylated oligonucleotide is eluted with ∼1 mL of a 20%
acetonitrile solution.
Materials
20% (v/v) and 100% acetonitrile
2 M triethylammonium acetate (TEAA)
Tritylated oligonucleotide in ammonia deprotection solution
3% (v/v) trifluoroacetic acid (TFA) 
1.5 M ammonium hydroxide
Oligonucleotide Purification Cartridges (OPC; PE Biosystems)
Vacuum manifold (Analytichem or National Scientific; optional) with an in-line
trap for waste and a water aspirator pump or small vacuum pump
5-mL disposable plastic syringes with exposed luer tips
Prepare the cartridge
1. Mount the OPC with a clamp and insert an empty 5-mL syringe barrel on the top of
the cartridge. 
Multiple cartridges can optionally be used with a vacuum manifold system.
2. Fill the syringe barrel with 5 mL of 100% acetonitrile. Insert and depress the plunger
to pass the reagent through the OPC (into an appropriate waste container) over an
elapsed time of ∼15 to 30 sec.
All reagents should be eluted from the OPC cartridge dropwise.
3. Repeat step 2 with 5 mL of 2 M TEAA.
Prepare the sample
4. Dilute the oligonucleotide ammonia solution (up to 20 OD units) with an equal
volume of water (e.g., normally ~1 mL).
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Apply the sample to the cartridge
5. Pass the diluted solution through the OPC at a rate of ∼1 drop/sec. Collect the eluate
and pass it through a second time.
6. Wash the OPC with 5 mL of 1.5 M ammonium hydroxide, then with 10 mL deionized
water, allowing the effluents to pass to waste.
7. Fill the syringe barrel with 5 mL of 3% trifluoroacetic acid (TFA) and pass ~2 mL
through the OPC to waste. Let stand for 5 min before passing the remainder through
to waste.
8. Pass 10 mL of deionized water through the OPC to waste.
9. For oligonucleotides >40 nt, pass 5 mL of 1.5 M ammonium hydroxide through the
column, to waste, then pass 5 mL of water through the OPC to waste. If oligonu-
cleotide is ≤40 nt, skip to step 10.
Collect the purified oligonucleotide
10. Elute the column, with 1 mL of 20% acetonitrile dropwise, and collect the purified
oligonucleotide in a 1.5-mL microcentrifuge tube. Quantify by OD measurement.
BASIC     
PROTOCOL 2
AFFINITY CARTRIDGE DESALTING OF DETRITYLATED
OLIGONUCLEOTIDES
This protocol details the use of an affinity cartridge to desalt and concentrate detritylated
oligonucleotides, with the capacity to yield up to 50 OD units of desalted oligonucleotide
per cartridge. No purification is effected, beyond removal of species that fail to bind to
the cartridge medium, which typically include salts, solvents, reagents, and very short
failure oligonucleotides. The OPC is one example of several commercially available
products that can render oligonucleotides free of salts, trace amounts of solvents, and
other small molecules by immobilizing, washing, and eluting on an affinity medium. This
desalting protocol is useful for (1) trityl-off oligonucleotides; (2) fluorescent dye–labeled,
biotin-labeled, and other labeled oligonucleotides; (3) RNA oligonucleotides, after desily-
lation/deprotection; (4) polyacrylamide gel purification extracts; and (5) anion-exchange
HPLC purification fractions. An alternative to this protocol is ethanol precipitation (UNIT
10.3).
Materials
0.1 M triethylammonium acetate (TEAA)
50% (v/v) acetonitrile
Additional reagents and equipment for cartridge purification (see Basic Protocol 1)
1. Mount cartridge and wash with acetonitrile and TEAA (see Basic Protocol 1, steps
1 to 3).
2. Concentrate up to 50 OD units of the oligonucleotide to dryness under vacuum. 
For maximum binding capacity, all organic solvents and ammonium hydroxide must be
removed.
3. Dissolve the completely dried oligonucleotide in 2 mL of 0.1 M TEAA.
4. Pass the oligonucleotide solution through the OPC at a rate of ∼1 drop/sec. Collect
the eluate and pass it through a second time.
5. Pass 15 mL of 0.1 M TEAA through the OPC to waste.






6. Elute the column with 1 mL of 50% acetonitrile dropwise, and collect the desalted




DMTr-selective cartridge purification sepa-
rates oligonucleotides by the same hydropho-
bic interaction principle as reversed-phase
HPLC (UNIT 10.5). Instead of a constant gradient
elution with an organic modifier (i.e., acetoni-
trile) as in HPLC, the cartridge method is a
batch-loading, washing, and elution process.
The costs and complexity of the cartridge meth-
ods, in general, are far less than HPLC or PAGE
(UNIT 10.4). However, the cartridge methods do
not provide concomitant analytical information
and are limited in capacity and efficiency of
purification. Other cartridges, with similar proto-
cols, are commercially available for purification
and desalting of oligonucleotides. Check with the
manufacturers for their optimum protocols.
The DMTr group at the 5′ terminus is very
hydrophobic and allows for specific binding of
the tritylated oligonucleotide with the station-
ary, hydrophobic polystyrene adsorbent of
OPC. Therefore, the product can be separated
from other components of the crude synthesis
mixture which do not bind. The crude tritylated
oligonucleotide is conveniently loaded from
the concentrated ammonium hydroxide cleav-
age/deprotection solution onto the OPC. Other
cartridges packed with reversed-phase silica
adsorbent, are not compatible with the low- and
high-pH reagents used in Basic Protocol 1.
Affinity desalting
The affinity desalting protocol (Basic Pro-
tocol 2) takes advantage of the hydrophobic
interactions of even untritylated oligonu-
cleotides with the cartridge adsorbent. In the
absence of the denaturing solution, ammonium
hydroxide, which limits binding, the desalting
protocol can bind a relatively large quantity of
oligonucleotide and remove large quantities of
impurities. Desalting removes impurities, such
as deprotection byproducts, which may hinder
some applications. Also, removal of UV-ab-
sorbing small molecules results in more accu-
rate UV quantitation. Basic Protocol 2 is par-
ticularly useful to remove the large quantities
of salts from anion-exchange HPLC purifica-
tion fractions (UNIT 10.5) and the buffer and gel
debris from PAGE purified oligonucleotides
(UNIT 10.4).
Many labeled oligonucleotides can be par-
tially separated from unlabeled oligonu-
cleotides by affinity cartridges (Basic Protocol
2). Fluorescent dyes, biotin, and many other
labels impart added hydrophobicity to confer
reasonable binding capacity. When attempting
to separate labeled oligonucleotides from un-
labled oligonucleotides, it may be necessary to
replace step 5 with 5 mL of 3% to 12% acetoni-
trile in 0.1 M TEAA. HPLC can be used to help
determine the best conditions for a particular
label.
Many cartridge purifications can be con-
ducted in parallel with a simple, commercially
available vacuum manifold, e.g., Vac Elut SPS
24, or Vac Elut 10-place manifold (Ana-
lytichem) with a 12 × 75-mm test tube rack.
The 12-position manifold (National Scientific)
is also suitable. In addition to vastly increased
throughput, manifolds require fewer manual
manipulations. The cartridges are mounted to
the suction element of the manifold and the
syringe barrels are merely filled with reagents,
remaining connected to the cartridge at all
times. Many commercial units give excellent
results, with no cross-contamination of sam-
ples (Applied Biosystems, 1991).
Size-exclusion filtration
Oligonucleotides can be separated from
smaller molecules by passage through a me-
dium, such as Sephadex, which allows separa-
tion based on molecular weight (this protocol
is not provided here). Large molecules follow
a shorter mean path length, due to exclusion
from the particle pores, than smaller molecules.
Unlike hydrophobic media in affinity methods,
size-exclusion media have little or no hydro-
phobic or ion-exchange interactions with oli-
gonucleotides. Size-exclusion filtration, also
called gel-filtration or gel-permeation chroma-
tography, is rapid and convenient but has lim-
ited separating power across a narrow mass
range. The Sephadex medium is available as
dry powder to be preswollen in aqueous solu-
tion, or prepacked in columns. The MicroSpin
and NAP columns (Pharmacia Biotech) have
quick protocols and require minimal labor.
Sample volumes of 100 to 150 µL are optimally
processed in a MicroSpin S-200 HR column in
a microcentrifuge, whereas sample volumes
between 0.2 and 2.5 mL require the appropri-







ately scaled NAP column under gravity flow.
The medium is equilibrated in the solution of
choice, such as water. The oligonucleotide
should be loaded in a minimum volume, such
as 200 µL water, and all eluate should be col-
lected. The oligonucleotide will elute in the
void volume, while smaller species will be
slightly retained.
A related technique utilizes disposable,
membrane-based, ultrafiltration devices, e.g.,
Microcon (Amicon), that operate in a micro-
centrifuge. In this method, the “large” oligonu-
cleotides (and other, higher-molecular-weight
nucleic acids) are retained above the mem-
brane, whereas the “small” impurities flow
through and are discarded. In effect, the oli-
gonucleotide is continuously concentrated in a
diminishing volume, which is an added benefit.
Disposable devices are available that can ac-




The efficiency of DMTr-selective cartridge
purification (Basic Protocol 1) depends largely
on the efficiency of the synthesis process. When
the detritylation, capping, and oxidation steps
during synthesis are efficient, only the correct-
sequence oligonucleotide should bear the
DMTr group, and a DMTr-selective purifica-
tion protocol can furnish a very pure product.
Moderately low coupling efficiency (95% to
97% average yield per cycle) will not limit
purification as long as these other steps in the
synthesis process are quantitative. Other side
reactions, such as depurination and extraneous
growth off the synthesis support, lead to trityl
heterogeneity and limit purification. Shorter
tritylated oligonucleotides have higher affinity
for the OPC than longer tritylated oligonu-
cleotides because they are more hydrophobic
and tend to be more pure than long oligonu-
cleotides. For example, a 20-nt oligonucleotide
may yield 5 OD units, whereas a 100-nt oli-
gonucleotide may yield only 1 OD unit of
purified product. Normally, when oligonu-
cleotides are purified (Basic Protocol 1) soon
after synthesis, e.g., within a few days, the trityl
group is stable in the ammonium hydroxide
solution. However, upon prolonged storage,
even in a freezer, the trityl group will cleave
regardless of the solution it is stored in. There-
fore, DMTr-selective purifications (see Basic
Protocol 1; also see UNIT 10.5 for reversed-phase
HPLC) should be conducted within a few days
after synthesis. Triethylammonium is the re-
sulting counterion of oligonucleotides purified
by Basic Protocols 1 and 2. If it is necessary to
exchange the triethylammonium counterion
with sodium, the oligonucleotide can be pre-
cipitated in ethanol and sodium acetate (UNIT
10.5) after cartridge purification.
In Basic Protocols 1 and 2, the initial ace-
tonitrile wash wets and swells the adsorbent.
The triethylammonium acetate wash removes
the acetonitrile and provides triethylam-
monium counter-ions to help bind the oligonu-
cleotide. The presence of ammonia in the load-
ing solution of the oligonucleotide provides the
desired denaturing medium but limits the bind-
ing capacity of tritylated oligonucleotides. If
ammonia is partially removed (by leaving for
several minutes in a Speedvac evaporator or
letting the sample remain uncapped for 15 min),
the binding capacity of DMTr oligonucleotides
will increase to yield ∼10 OD units of purified,
detritylated oligonucleotide. A dilute ammonia
wash follows loading to insure that non-DMTr
oligonucleotides have been removed. The
water wash removes residual ammonia so it will
not neutralize the TFA (trifluoroacetic acid) in
the following step. Detritylation with 5 mL of
3% TFA requires 5 min. The detritylation can
sometimes be observed as a slight orange or pink
blush to the support. Even though it no longer
has a trityl group, at neutral and low pH, the
purified oligonucleotide is retained while
washing with water to remove residual acidic
TFA.
For oligonucleotides >40 nt, the second di-
lute ammonia wash serves to remove shorter
oligonucleotides while allowing longer oli-
gonucleotide to be retained. A water wash fol-
lows to remove residual ammonium hydroxide.
Elution of the purified oligonucleotide occurs
with 20% acetonitrile. The cleaved di-
methoxytrityl alcohol remains on the OPC and
does not contaminate the purified oligonu-
cleotide.
Reuse of any purification matrix can lead to
problems with carryover and sample contami-
nation. Avoiding these problems is especially
important in synthetic DNA applications be-
cause of the potential for errant priming and
hybridization. Analytical HPLC studies dem-
onstrate that ∼5% of an oligonucleotide product
is carried over as a contaminant into a second,
different oligonucleotide sequence upon reuse
of a purification cartridge. Also, the DMTr that
is released upon TFA treatment is very tightly
bound, resulting in diminished capacity and
selectivity for DMTr oligonucleotides. The saf-






est, most reliable solution is a disposable one-
time use format.
For longer-term storage (i.e., >6 months),
oligonucleotides that have been purified by
OPC (see Basic Protocol 1) should be stored as
dry solids at –15°C.
Anticipated Results
In Basic Protocol 1, 10 to 20 OD units of a
crude, tritylated oligonucleotide (i.e., an entire
40 nmol scale and most, or all of a 0.2 µmol
scale synthesis) can be loaded, to yield 1 to 10
OD units of purified product. The yield depends
on initial purity, length, and concentration of
ammonium hydroxide in the loading solution.
Yield is measured in OD units by UV absor-
bance at 260 nm, converted to mass by using
the approximation of 33 µg per OD unit. Oli-
gonucleotides purified by Basic Protocol 1 are
typically >90% pure by integrated peak area
HPLC analysis, which compares well with
HPLC (UNIT 10.5) and PAGE (UNIT 10.4) methods.
In Basic Protocol 2, the yield can be as high as
50 OD units of desalted product.
Synthetic oligoribonucleotides (RNA) can
also be desalted and purified by DMTr-selec-
tive, affinity cartridges (Mullah and Andrus,
1996). Purification of phosphorothioate oli-
gonucleotide analogs by the cartridge method
is also very efficient. Since phosphorothioates
are more hydrophobic, use 1 mL of 35% ace-
tonitrile to elute them (Basic Protocol 1, step 10).
Time Considerations
Basic Protocol 1 requires ∼15 to 20 min.
Basic Protocol 2 requires ∼10 to 15 min. Use
of a vacuum manifold will speed up purification
of even a single oligonucleotide and results in
large time savings when purifying a larger num-
ber. For example, 10 oligonucleotides can be
purified by Basic Protocol 1 on a vacuum mani-
fold in <30 min.
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